Harpoon Therapeutics Inc.

(NASDAQ:HARP) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.

Contact Information

Website: www.harpoontx.com
Email: info@harpoontx.com
Main Phone: +1 650 443-7400
Address: 131 Oyster Point Boulevard
Address 2: Suite 300
State: CA
City / Town: South San Francisco
Country: US
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Gerald McMahon
Employees: 78
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A